Terry L. Ng

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres, Alexander Drilon, Amélie Lusque et al. · Annals of Oncology · 2019 · 1.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy

Megan M. Tu, Francis Y. F. Lee, Robert T. Jones et al. · Science Advances · 2019 · 127 citations · Full text

Medicine, Immunology, Oncology +17

Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre

Iryna Kuchuk, Brian Hutton, Patrícia Moretto et al. · Journal of bone oncology · 2013 · 118 citations · Full text

Medicine, Oncology, Breast Oncology +15

Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?

Terry L. Ng, Brian Hutton, Mark Clemons · The Oncologist · 2015 · 93 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion

Kurtis D. Davies, Terry L. Ng, Adriana Estrada‐Bernal et al. · JCO Precision Oncology · 2017 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17